コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 iocarcinoma, one hemangioma, and one biliary hamartoma).
2 rome characterized by benign proliferations (hamartomas).
3 enburg complexes (VMC; also known as biliary hamartomas).
4 ripapillary and macular variants of combined hamartoma.
5 y eyes with a clinical diagnosis of combined hamartoma.
6 erto unsolved cases of sporadic hypothalamic hamartoma.
7 of the tumour typical for retinal astrocytic hamartoma.
8 lly confirmed to have a bilateral multifocal hamartoma.
9 ed to hepatocellular carcinoma and bile duct hamartoma.
10 neovascularization in peripapillary combined hamartoma.
11 a, fistulas, hypertelorism, cleft palate and hamartoma.
12 uterine leiomyomas, and pulmonary chondroid hamartomas.
13 erapeutic potential for the treatment of TSC hamartomas.
14 in the genesis of human basaloid follicular hamartomas.
15 s pathway may have benefit in control of TSC hamartomas.
16 ogression of the epithelial component of the hamartomas.
17 ported as Wilms tumors, nephroblastomas, and hamartomas.
18 ere, we present the genomic landscape of TSC hamartomas.
19 terized by seizures, mental retardation, and hamartomas.
20 k-1 which may be useful to resolve TSC brain hamartomas.
21 pared with more indolent basaloid follicular hamartomas.
22 d intestinal malrotation with myofibromas or hamartomas.
23 ascular tufts are rare iris stromal vascular hamartomas.
24 on whether they are considered neoplasms or hamartomas.
25 85% of CS patients had gastrointestinal (GI) hamartomas.
26 ract corresponding to these gastrointestinal hamartomas.
27 cal cortical dysplasia (5), heterotopia (2), hamartoma (3), cortical duplication (1), polymicrogyria
29 anomalies affecting the brain (hypothalamic hamartoma and microcephaly), heart (atrioventricular sep
30 No reported cases of GCPS have hypothalamic hamartoma and PHS does not cause hypertelorism or broade
31 mon of these uncommon tumors are mesenchymal hamartoma and undifferentiated embryonal sarcoma, which
32 syndrome, which is characterized by multiple hamartomas and a high proclivity for developing cancer.
33 ome (CS), which is characterized by multiple hamartomas and a high risk of breast and thyroid cancers
34 s syndrome, which is characterized by benign hamartomas and a susceptibility to malignant epithelial
38 ome (CS), which is characterized by multiple hamartomas and an increased risk of breast, thyroid, and
39 disorder associated with the development of hamartomas and benign tumors in a variety of tissues, in
40 rome, a rare familial trait characterized by hamartomas and by predisposition to cancer of the breast
41 in the LKB1/STK11 gene cause characteristic hamartomas and freckling to develop in patients with Peu
43 ody of anecdotal evidence about hypothalamic hamartomas and gelastic seizures, many questions still r
44 rder that is characterized by benign tumors (hamartomas and hamartias) involving multiple organ syste
45 eghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers
49 rapamycins in controlling the growth of TSC hamartomas and other tumors that depend on elevated mTOR
50 erves as a resource into the origin of these hamartomas and provides a framework that unifies genomic
53 Multiple tongue deformities including cleft, hamartoma, and ankyloglossia are also seen in ciliopathi
54 midline bald patches, generalized follicular hamartoma, and loose anagen syndrome, may be associated
55 ess retinal shadowing with congenital simple hamartoma, and photoreceptor loss and retinal thinning o
57 r angiomyolipomas, forehead plaques, retinal hamartomas, and liver angiomyolipomas) were very rare or
59 ll cells are the inciting cells for TSC skin hamartomas, and suggest that studies on hamartomas will
60 rowth potential of the great majority of TSC hamartomas, and the influence of genetic background on p
62 of mesenchymal cells in leiomyomas, lipomas, hamartomas,and other diseases has been linked to the hig
63 of a search for somatic mutations in paired hamartoma- and leukocyte-derived DNA samples from 38 ind
67 risk of renal cell carcinoma (<2%), but the hamartomas are of stromal origin and patients do not dev
68 rder tuberous sclerosis, in which widespread hamartomas are seen, some of which have a high level of
69 cell carcinoma (BCC) and basaloid follicular hamartoma, are associated with aberrant Hedgehog (Hh) si
73 role in the pathogenesis of gastrointestinal hamartomas as well as several cancers, including pancrea
74 peractivated in many human tumors, including hamartomas associated with tuberous sclerosis complex (T
76 ure of these diseases is a predisposition to hamartomas, benign tumours containing differentiated but
77 10.3%) were diagnosed as basaloid follicular hamartomas (BFHs), 10 (34.5%) classified as infundibuloc
79 hese phenotypes model characteristics of TSC hamartomas called subependymal giant cell astrocytomas (
80 ogyria, interhemispheric cysts, hypothalamic hamartoma, callosal anomalies, and hypoplasia of brainst
82 egression, thought to be a characteristic of hamartomas, can be seen in neoplasms of other types as w
83 regions are most affected by the location of hamartomas causing laughing versus other types of seizur
84 uman development that comprises hypothalamic hamartoma, central polydactyly, and other malformations.
86 0 kb of HMGI(Y), and one pulmonary chondroid hamartoma contained an intragenic fusion juxtaposing HMG
87 ) mice had shortened lifespans and extensive hamartomas containing abnormal tortuous, dilated vessels
88 ith tuberous sclerosis complex (TSC) develop hamartomas containing biallelic inactivating mutations i
89 ppressor gene disorder characterized by skin hamartomas, cystic lung disease, and renal cell carcinom
90 dings with depth electrodes implanted in the hamartoma demonstrated focal seizure origin from the ham
94 In the tuberous sclerosis complex (TSC), hamartomas develop in multiple organs because of mutatio
95 al dominant genetic disorder in which benign hamartomas develop in multiple organs, caused by mutatio
96 ikingly similar to human basaloid follicular hamartomas develop, but BCCs do not arise even in elderl
97 g mice potently inhibited epithelial bud and hamartoma development without affecting Hh signaling.
103 autosomal dominant disease characterized by hamartoma formation in various organs and is caused by m
105 mice closely resemble the retinal astrocytic hamartomas found in human tuberous sclerosis (TSC) disea
106 n the basis of linkage analysis or because a hamartoma from the patient showed loss of heterozygosity
108 eta-catenin signaling in epithelial buds and hamartomas from mice expressing an oncogene, M2SMO, lead
109 ons such as cortical tubers and subependymal hamartoma/giant cell astrocytomas are major causes of TS
112 ilar to the Lkb1(+/-) mice, gastrointestinal hamartomas have also been detected in the mice with thes
118 seizures demonstrated hyperperfusion in the hamartomas, hypothalamic region, and thalamus without co
119 eyes of 49 patients diagnosed with combined hamartoma identified 18 (36%) peripapillary lesions, 27
120 nalysis of peripapillary vs macular combined hamartoma identified differences in the following featur
121 s identified in an adenocarcinoma but not in hamartomas, implying that allelic loss of these two regi
129 x (TSC) is characterized by the formation of hamartomas in multiple organs resulting from mutations i
131 autosomal dominant disorder characterized by hamartomas in one or more organs, including the brain, s
132 rly gatekeeper regulating the development of hamartomas in PJS and suggest that hamartomas may be pat
133 odalities for the treatment and detection of hamartomas in PJS patients, and potential for the screen
134 C2 gene, characterized by the development of hamartomas in various organs and neurological manifestat
135 ystic nephroma, and nasal chondromesenchymal hamartoma) in 102 female and male nonproband DICER1 carr
137 ly upregulated in mouse and human follicular hamartomas, in contrast to the high levels detected in B
138 dominant disease characterized by multiorgan hamartomas, including renal angiomyolipomas and pulmonar
139 zygosity at the TSC2 locus in the associated hamartomas indicate that TSC2 functions as a tumour supp
140 roblast-like cells grown from human TSC skin hamartomas induced normal human keratinocytes to form ha
141 elial cyst, cystic lymphangioma, hemangioma, hamartoma, infarction, sclerosing angiomatous nodular tr
142 inant cellular phenotype of the subependymal hamartomas is astroglial and suggests that the neuronal
143 enodermatosis characterized by hair follicle hamartomas, kidney tumors and spontaneous pneumothorax.
145 opment of hamartomas in PJS and suggest that hamartomas may be pathogenetic precursors of adenocarcin
148 (n = 4), focal nodular hyperplasia (n = 2), hamartoma (n = 1), and metastatic embryonal sarcoma (n =
149 (n = 9); group V, proliferating neurocristic hamartoma (n = 1); and group VI, melanoma arising in con
150 = 18; 3%), coloboma (n = 17; 3%), astrocytic hamartoma (n = 15; 2%), combined hamartoma of retina and
153 astrocytic hamartoma (n = 15; 2%), combined hamartoma of retina and retinal pigment epithelium (n =
156 tomography (OCT) characteristics of combined hamartoma of the retina and retinal pigment epithelium (
157 on and retinal disorganization with combined hamartoma of the retina and retinal pigment epithelium,
160 e a group of disorders that feature multiple hamartomas of the central and peripheral nervous system,
162 neous pigmentation, predisposition to benign hamartomas of the gastrointestinal tract and also to sev
163 , a genodermatosis characterized by multiple hamartomas of the hair follicle (fibrofolliculoma), pred
164 ce of two or more Lisch nodules (melanocytic hamartomas of the iris) is one of seven diagnostic crite
171 sias had better outcome than heterotopia and hamartoma regardless of type of surgical procedure.
172 ficantly different risk levels for classical hamartoma-related features (odds ratio [OR] range of 4.1
173 Stereotactic radiofrequency lesioning of the hamartoma resulted in seizure remission without complica
174 umors, such as retinoblastoma and astrocytic hamartoma, reveals full-thickness replacement of the ret
176 le for Cowden disease, an autosomal dominant hamartoma syndrome associated with thyroid and breast tu
178 erous sclerosis (TSC) is a relatively common hamartoma syndrome caused by mutations in either of two
181 berous sclerosis complex (TSC) is a familial hamartoma syndrome in which renal involvement is common
182 ed in Cowden syndrome, an inherited multiple hamartoma syndrome that includes predisposition to FTC.
183 me (CS) is a difficult-to-recognize multiple hamartoma syndrome with high risks of breast, thyroid, a
186 sing two cell culture models of the familial hamartoma syndrome, tuberous sclerosis, we show here tha
189 ressor gene PTEN have been implicated in two hamartoma syndromes that exhibit some clinical overlap,
190 Bannayan-Riley-Ruvalcaba (BRR) syndrome, two hamartoma syndromes with an increased risk of breast and
192 ay be a common molecular basis, not only for hamartoma syndromes, but also for other cellular hypertr
194 ed mTOR activity are associated with several hamartoma syndromes, including tuberous sclerosis comple
195 coded by genes responsible for several other hamartoma syndromes, LKB1, TSC1/2, and PTEN, have been s
196 ould easily be confused with other inherited hamartoma syndromes, such as Bannayan-Riley-Ruvalcaba sy
200 dentified as the susceptibility gene for two hamartoma syndromes: Cowden disease (CD; MIM 158350) and
201 of PTEN are present in individuals with two hamartoma syndromes: Cowden Syndrome, associated with a
203 nd SD-OCT aid in the detection of astrocytic hamartomas that are not visible on clinical examination
204 e development of PHTS and also reverses skin hamartomas that have reached advanced stages in mice.
205 nd SD-OCT detected occult retinal astrocytic hamartomas that were not observed on clinical examinatio
206 croarray on surgically resected hypothalamic hamartoma tissue and paired leukocyte-derived DNA from 2
208 sease genes that cause sporadic hypothalamic hamartoma to bi-allelic (one germline/one somatic) varia
209 utational events underlie the progression of hamartomas to adenocarcinomas, and some of these somatic
210 ith Krt5 in vivo, delays basaloid follicular hamartoma tumor initiation and growth in mice with const
211 drome, juvenile polyposis syndrome, the PTEN hamartoma tumor syndrome (including Cowden's syndrome an
212 hromosome ten (PTEN) are diagnosed with PTEN hamartoma tumor syndrome (PHTS) and are at high risk for
217 ions receive the molecular diagnosis of PTEN Hamartoma Tumor Syndrome (PHTS), an inherited cancer pre
218 Germline PTEN pathogenic variants cause PTEN hamartoma tumor syndrome (PHTS), associated with lipoma
219 ermline pathogenic PTEN mutations cause PTEN hamartoma tumor syndrome (PHTS), featuring various benig
221 se and tensin homolog (PTEN) gene cause PTEN hamartoma tumor syndrome (PHTS), which includes cataract
227 romosome 10) is the underlying cause of PTEN hamartoma tumor syndrome and a wide variety of human can
228 , macrocephaly, and speckled penis, the PTEN hamartoma tumor syndrome spectrum has broadened to inclu
229 es that are jointly referred to as the "PTEN hamartoma tumor syndrome" (PHTS) and include Cowden synd
230 iedemann syndrome/ hemihypertrophy, and PTEN hamartoma tumor syndrome, among others, are reviewed.
231 ls the distinct mutational landscape of PTEN hamartoma tumor syndrome-associated thyroid cancers from
234 ch are collectively referred to as the "PTEN hamartoma tumor syndrome." The human PTEN gene has been
235 hatase, have been implicated in at least two hamartoma tumor syndromes that exhibit some clinical ove
236 pping clinical phenotypes (known as the PTEN hamartoma tumor syndromes), including Cowden's syndrome
237 mosome ten (PTEN) are found in two inherited hamartoma tumor syndromes: Cowden syndrome, which has a
239 Bannayan-Riley-Ruvalcaba syndrome (BRR), two hamartoma-tumor syndromes with an increased risk of brea
244 riety of human cancers and several inherited hamartoma tumour syndromes, including Cowden syndrome, w
246 Bannayan-Riley-Ruvalcaba syndrome (BRR), two hamartoma-tumour syndromes, and somatic PTEN alterations
248 r structural changes over time in astrocytic hamartomas using SD-OCT may be beneficial for monitoring
249 eatures, congenital anomalies such as tongue hamartoma, variable degrees of intellectual disability,
250 elangiectasia type 2 and solitary astrocytic hamartoma was detected as a unique and rare observation.
251 ed that the atypical location of the retinal hamartoma was secondary to the abnormal globe developmen
252 cases of gelastic epilepsy and hypothalamic hamartoma, we aimed to address these questions by analys
256 elded lesions resembling basaloid follicular hamartomas, which have previously been linked to low-lev
257 r characterized by widespread development of hamartomas, which is caused by mutations in either TSC1
258 skin hamartomas, and suggest that studies on hamartomas will provide insights into tissue morphogenes
261 ts recapitulated characteristics of TSC skin hamartomas with increased mammalian target of the rapamy